Palatin Tech To Cut Work Force In Half, Do Reverse Stock Split – Wall Street Journal

Palatin Tech To Cut Work Force In Half, Do Reverse Stock Split
Wall Street Journal
Palatin has been developing bremelanotide for male and female sexual dysfunction and PL-3994 for acute severe asthma. The company plans to submit plans for
Palatin Announces Strategic Realignment of OperationsPR Newswire (press release)
Palatin Reducing Workforce By 50%; To Effect 1-for-10 Reverse Stock Split RTT News

all 17 news articles »

View full post on asthma – Google News

An alternate weapon to help adults with asthma – Milwaukee Journal Sentinel (blog)


CBC.ca

An alternate weapon to help adults with asthma
Milwaukee Journal Sentinel (blog)
Until now adults with poorly-controlled asthma have been forced to increase the dose of corticosteroids or to supplement them with long-acting beta agonists
Possible Alternative Therapy for Adults with Poorly Controlled Asthmanews Stories
COPD Drug Spiriva May Also Benefit Those with AsthmaeMaxHealth
Now, alternate therapy for adults with poorly controlled asthmaSify
Denver Post –FiercePharma –allvoices
all 340 news articles »

View full post on asthma – Google News

BSX To Buy California Asthma Treatment Co. – Worcester Business Journal

BSX To Buy California Asthma Treatment Co.
Worcester Business Journal
Asthmatx makes catheter-based devices for adults with asthma that is not well-controlled. In a statement, Ray Elliott, BSX's president and CEO,
Boston Scientific agrees to buy asthma companyBoston Globe
Boston Scientific to Buy Asthmatx for $193.5 Million Gaining Asthma DeviceBloomberg
Boston Scientific to Buy Asthmatx for Up to $443.5 MillionWall Street Journal
Reuters –Mass High Tech –Medical News Today
all 68 news articles »

View full post on asthma – Google News